VACCINES WITH APPLICATION OF VESICLES BASED ON GNA 1870 OF BROAD SPECTRUM OF ACTION FOR PREVENTION OF DISEASES, CAUSED BY NEISSERIA MENINGITIDIS Russian patent published in 2011 - IPC A61K39/95 A61K35/74 C12P21/00 A61P43/00 

FIELD: medicine, pharmaceutics.

SUBSTANCE: in invention described is composition for causing immune reaction against Neisseria meningitidis basing on vesicles, separated from bacteria N. meningitidis, in which endogenous gen GNA 1870 is inactivated and which is transformed by gene construction, coding polypeptide GNA 1870. Such bacterium insures super-expression of GNA 1870 polypeptide in vesicles of N. meningitidis. Composition can additionally contain antigen vesicle from second, third bacteria of N. meningitidis, on condition that both bacteria are genetically different from each other and from said first bacteria. GNA 1870 polypeptides, expressed by first, second and third bacteria are also genetically different from each other. Invention describes method of exciting immune reaction against bacteria of species Neisseria by introduction to mammal of composition based on vesicles, containing polypeptide GNA 1870, as well as method of obtaining composition based on vesicles, obtained as a result of culturing in proper way prepared bacteria, by their mixing with pharmaceutically acceptable carrier.

EFFECT: invention provides protective immunity against broad spectrum of N meningitidis strains, including strains N meningitidis of serogroup B.

45 cl, 20 dwg, 5 tbl, 8 ex